Metraipolis › archive › dc_02bcd40b4afa

Mfsd2a-Targeted Therapy for Ischemic Stroke: Mechanisms, Evidence, and Future Prospects — Europe PMC PMID:41358569

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41358569
DOI: 10.1002/cns.70684
License (as archived): solo-consultazione
Archived: 2026-11-08T03:23:37.260Z
SHA-256 of the archived text: 13d808a3bd792d79d16c8596d1dd03ef05a2f5abf435f4b2764ad0c9fe995f48
Stable URL of this page: https://metraipolis.com/documento/dc_02bcd40b4afa

How to cite

Mfsd2a-Targeted Therapy for Ischemic Stroke: Mechanisms, Evidence, and Future Prospects — Europe PMC PMID:41358569 — Europe PMC (en), https://europepmc.org/article/MED/41358569 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02bcd40b4afa (Metraipolis archive dc_02bcd40b4afa, sha256 13d808a3bd792d79d16c8596d1dd03ef05a2f5abf435f4b2764ad0c9fe995f48)

BibTeX

@misc{dc02bcd40b4afa,
  title = {Mfsd2a-Targeted Therapy for Ischemic Stroke: Mechanisms, Evidence, and Future Prospects — Europe PMC PMID:41358569},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41358569},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02bcd40b4afa; sha256 13d808a3bd792d79d16c8596d1dd03ef05a2f5abf435f4b2764ad0c9fe995f48},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41358569. Agents can read the archived copy with the MCP tool read_document.